Interview with Martha Carlin

Over two decades of Parkinsons research focused on the causes of symptoms and what you can do about them are included in Martha Carlin’s new book titled Connected. My interview with her is a must watch for anyone currently confronting symptoms of Parkinsons.

The Link to Martha Carlin’s New Book inspired by Two Decades of Parkinsons Research

Connected: love loss in the unseen forces behind chronic disease https://biotiquest.com/products/connected-by-martha-carlin 

Here is the List of Questions I asked Martha:

1. Martha, you’ve been researching Parkinson’s for more than two decades. For listeners who may not know your story, what set you on this path?
2. Your new book is called Connected. Why did you choose that title?
3. What do you hope people living with Parkinson’s take away from the book?
4. Looking back, what was the biggest misconception you had about Parkinson’s when John was first diagnosed?
5. After 24 years of research, what do you believe now that you didn’t believe then?
6. Many people still think of Parkinson’s as a disease of dopamine loss. Why do you believe that view is incomplete?
7. You’ve often described Parkinson’s as a systems problem rather than simply a brain disease. What do you mean by that?
8. The gut microbiome has become a major focus of Parkinson’s research. Why is the gut so important?
9. What have we learned about Parkinson’s and the microbiome that we didn’t know twenty years ago?
10. If you had to identify one overlooked factor driving chronic illness today, what would it be?
11. You recently published a paper with physicist Barry Ninham. What question were you trying to answer?
12. For listeners who have never heard the term glycocalyx, what is it and why should they care?
13. Your paper suggests that the glycocalyx may be a critical interface between microbes, toxins, inflammation, and the body. Can you explain that concept?
14. How might glycocalyx damage help explain why so many different environmental exposures are linked to Parkinson’s?
15. Why do you think this structure has received so little attention compared to genes, proteins, and neurotransmitters?
16. Does this framework change how we think about the progression of Parkinson’s disease?
17. What role do bacterial products like endotoxin play in this model?
18. If someone listening today has Parkinson’s, what practical steps can they take to better support their body’s protective barriers and microbiome?
19. What research questions are you most excited to pursue next?
20. After everything you’ve learned through John’s journey and your own research, what gives you the most hope for the future of Parkinson’s recovery

Robert